FDA.reportPublic FDA data

brimonidine 0.0033 MG/MG Topical Gel [Mirvaso]

RxCUI
1437709
RxNorm name
brimonidine 0.0033 MG/MG Topical Gel [Mirvaso]
Display name
brimonidine 0.0033 MG/MG Topical Gel [Mirvaso]
Full name
brimonidine 0.0033 MG/MG Topical Gel [Mirvaso]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:28

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MirvasoBRIMONIDINE TARTRATEGalderma Laboratories, L.P.f6a4353f-ae69-4214-901f-e5d42a6fbde72024-10-24Warnings, Adverse reactionsExact identifier
rxcui: 1437709

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f6a4353f-ae69-4214-901f-e5d42a6fbde7Mirvaso 0.33 % Topical Gel [PSN] · brimonidine 0.0033 MG/MG Topical Gel [Mirvaso] [SBD] · Mirvaso 0.0033 MG/MG Topical Gel [SY] · Mirvaso 0.33 % (as brimonidine tartrate 5 mg/ml) Topical Gel [SY]411These highlights do not include all the information needed to use MIRVASO ® safely and effectively. See full prescribing information for MIRVASO. MIRVASO (brimonidine) topical gel Initial U.S. Approval: 199620241024